Вы находитесь на странице: 1из 1

Federal Register / Vol. 71, No.

183 / Thursday, September 21, 2006 / Notices 55203

Agenda: To review and evaluate grant Date: October 23, 2006. would constitute a clearly unwarranted
applications. Time: 4 p.m. to 5:30 p.m. invasion of personal privacy.
Place: Hyatt Regency Bethesda, One Agenda: To review and evaluate grant
Bethesda Metro Center, 7400 Wisconsin applications. Name of Committee: National Institute of
Avenue, Bethesda, MD 20814. Place: National Institutes of Health, Two Allergy and Infectious Diseases Special
Contact Person: Michael L. Bloom, PhD, Democracy Plaza, 6707 Democracy Emphasis Panel, Pharmaceutical and
Scientific Review Administrator, EP Review Boulevard, Bethesda, MD 20892, (Telephone Chemical Resources for AIDS Drug
Branch, NIH–NIAMS Institute, One Conference Call). Development.
Democracy Plaza, Room 820, MSC 4872, Contact Person: Maria E. Davila-Bloom, Date: October 2–3, 2006.
6701 Democracy Blvd, Bethesda, MD 20892– PhD, Scientific Review Administrator, Time: 8 a.m. to 5 p.m.
4872, 301–594–4953, Review Branch, DEA, NIDDK, National Agenda: To review and evaluate contract
Michael_Bloom@nih.gov. Institutes of Health, Room 758, 6707 proposals.
(Catalogue of Federal Domestic Assistance Democracy Boulevard, Bethesda, MD 20892– Place: Residence Inn Bethesda, 7335
Program Nos. 93.846, Arthritis, 5452, (301) 594–7637, davila- Wisconsin Avenue, Bethesda, MD 20814.
Musculoskeletal and Skin Diseases Research, bloomm@extra.niddk.nih.gov. Contact Person: Darren D. Sledjeski PhD,
National Institutes of Health, HHS) Name of Committee: National Institute of Scientific Review Administrator, NIAID,
Diabetes and Digestive and Kidney Diseases DEA, Scientific Review Program, Room 3253,
Dated: September 13, 2006. Special Emphasis Panel, Kidney Disease 6700B Rockledge Drive, MSC–7616,
Anna Snouffer, Ancillary Studies. Bethesda, MD 20892–7616, (301) 451–2638.
Acting Director, Office of Federal Advisory Date: October 31, 2006. Name of Committee: National Institute of
Committee Policy. Time: 1 p.m. to 5 p.m. Allergy and Infectious Diseases Special
[FR Doc. 06–7915 Filed 9–20–06; 8:45 am] Agenda: To review and evaluate grant Emphasis Panel, Center for AIDS Research.
applications. Date: October 5–6, 2006.
BILLING CODE 4140–01–M
Place: National Institutes of Health, Two Time: 8 a.m. to 5:30 p.m.
Democracy Plaza, 6707 Democracy Agenda: To review and evaluate grant
Boulevard, Bethesda, MD 20892, (Telephone applications.
DEPARTMENT OF HEALTH AND Conference Call). Place: Clarion Hotel, 8400 Wisconsin
HUMAN SERVICES Contact Person: Atul Sahai, PhD, Scientific Avenue, Bethesda, MD 20814.
Review Administrator, Review Branch, DEA, Contact Person: Eleazar Cohen, PhD,
National Institutes of Health NIDDK, National Institutes of Health, Room Scientific Review Administrator, Division of
908, 6707 Democracy Boulevard, Bethesda, Extramural Activities, NIH/NIAID/DHHS,
National Institute of Diabetes and MD 20892–5452, (301) 594–2242, 6700B Rockledge Drive, Room 3129,
Digestive and Kidney Diseases; Notice sahaia@extra.niddk.nih.gov. Bethesda, MD 20892, (301) 435–3564,
of Closed Meetings (Catalogue of Federal Domestic Assistance ec17w@nih.gov.
Program Nos. 93.847, Diabetes, (Catalogue of Federal Domestic Assistance
Pursuant to section 10(d) of the Endocrinology and Metabolic Research; Program Nos. 93.855, Allergy, Immunology,
Federal Advisory Committee Act, as 93.848, Digestive Disease and Nutrition and Transplantation Research; 93.856,
amended (5 U.S.C. Appendix 2), notice Research; 93.849, Kidney Diseases, Urology Microbiology and Infectious Diseases
is hereby given of the following and Hematology Research, National Institutes Research, National Institutes of Health, HHS).
meetings. of Health, HHS)
The meetings will be closed to the Dated: September 13, 2006.
Dated: September 13, 2006.
public in accordance with the Anna Snouffer,
Anna Snouffer,
provisions set forth in sections Acting Director, Office of Federal Advisory
Acting Director, Office of Federal Advisory Committee Policy.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Committee Policy.
as amended. The grant applications and [FR Doc. 06–7919 Filed 9–20–06; 8:45 am]
[FR Doc. 06–7918 Filed 9–20–06; 8:45 am]
the discussions could disclose BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning DEPARTMENT OF HEALTH AND
DEPARTMENT OF HEALTH AND
individuals associated with the grant HUMAN SERVICES
HUMAN SERVICES
applications, the disclosure of which
would constitute a clearly unwarranted National Institutes of Health
National Institutes of Health
invasion of personal privacy. National Institute on Alcohol Abuse
Name of Committee: National Institute of National Institute of Allergy and
and Alcoholism; Notice of Closed
Diabetes and Digestive and Kidney Diseases Infectious Diseases; Notice of Closed
Meeting
Special Emphasis Panel, Translational Meetings
Research. Pursuant to section 10(d) of the
Date: October 12, 2006.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as Federal Advisory Committee Act, as
Time: 8 a.m. to 5 p.m.
amended (5 U.S.C. Appendix 2), notice amended (5 U.S.C. Appendix 2), notice
Agenda: To review and evaluate grant
applications. is hereby given of the following is hereby given of the following
Place: Bethesda Park Hotel, 8400 meetings. meeting.
Wisconsin Avenue, Bethesda, MD 20814. The meetings will be closed to the The meeting will be closed to the
Contact Person: Michele L. Barnard, PhD, public in accordance with the public in accordance with the
Scientific Review Administrator, Review provisions set forth in sections provisions set forth in sections
Branch, DEA, NIDDK, National Institutes of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Health, Room 753, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
as amended. The contract proposals and as amended. The grant applications and
594–8898, barnardm@extra.niddk.nih.gov. the discussions could disclose the discussions could disclose
jlentini on PROD1PC65 with NOTICES

Name of Committee: National Institute of


confidential trade secrets or commercial confidential trade secrets or commercial
Diabetes and Digestive and Kidney Diseases property such as patentable material, property such as patentable material,
Special Emphasis Panel, Folic Acid for and personal information concerning and personal information concerning
Vascular Outcome Reduction in individuals associated with the contract individuals associated with the grant
Transplantation. proposals, the disclosure of which applications, the disclosure of which

VerDate Aug<31>2005 16:30 Sep 20, 2006 Jkt 208001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\21SEN1.SGM 21SEN1

Вам также может понравиться